Johnson & Johnson Cost of Goods Sold (Deprecated 2018-01-31)
Johnson & Johnson (JNJ) reported Cost of Goods Sold (Deprecated 2018-01-31) of $27.09 billion for the 12-month period ending 2018-12-30, per its 10-K filed 2019-02-20.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2019-02-20
- Johnson & Johnson cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-07-01 was $6.93B, a 18.49% increase year-over-year.
- Johnson & Johnson cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-04-01 was $6.61B, a 22.28% increase year-over-year.
- Johnson & Johnson cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $7.33B, a 29.98% increase year-over-year.
- Johnson & Johnson cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-10-01 was $6.90B, a 25.81% increase year-over-year.
- Johnson & Johnson cost of goods sold (deprecated 2018-01-31) for fiscal 2018 was $27.09B, a 6.49% increase from fiscal 2017.
- Johnson & Johnson cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $25.44B, a 16.75% increase from fiscal 2017.
- Johnson & Johnson cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $21.79B, a 1.17% increase from fiscal 2016.
- Johnson & Johnson cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $21.54B, a 5.32% decline from fiscal 2014.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-30 | $27.09B 10-K · filed 2019-02-20 | ||||||
| 2018-07-01 | $6.93B 10-Q · filed 2018-08-02 | $13.54B 10-Q · filed 2018-08-02 | $20.87B derived: sum of 3 quarters · filed 2019-02-20 | $27.77B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2018-04-01 | $6.61B 10-Q · filed 2018-05-01 | $13.94B derived: sum of 2 quarters · filed 2019-02-20 | $20.84B derived: sum of 3 quarters · filed 2019-02-20 | $26.69B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-12-31 | $7.33B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $14.23B derived: sum of 2 quarters · filed 2019-02-20 | $20.08B derived: sum of 3 quarters · filed 2019-02-20 | $25.44B 10-K · filed 2019-02-20 | $25.35B 10-K · filed 2018-02-21 | ||
| 2017-10-01 | $6.90B 10-Q · filed 2017-11-02 | $12.75B derived: sum of 2 quarters · filed 2018-08-02 | $18.11B 10-Q · filed 2017-11-02 | $23.80B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-07-02 | $5.85B 10-Q · filed 2018-08-02 | $5.82B 10-Q · filed 2017-08-03 | $11.26B 10-Q · filed 2018-08-02 | $11.21B 10-Q · filed 2017-08-03 | $16.89B derived: sum of 3 quarters · filed 2019-02-20 | $22.38B derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-04-02 | $5.41B 10-Q · filed 2018-05-01 | $5.39B 10-Q · filed 2017-05-08 | $11.05B derived: sum of 2 quarters · filed 2019-02-20 | $16.53B derived: sum of 3 quarters · filed 2019-02-20 | $21.87B derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-01-01 | $5.64B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $11.12B derived: sum of 2 quarters · filed 2019-02-20 | $16.46B derived: sum of 3 quarters · filed 2019-02-20 | $21.79B 10-K · filed 2019-02-20 | $21.68B 10-K · filed 2017-02-27 | ||
| 2016-10-02 | $5.49B 10-Q · filed 2017-11-02 | $10.82B derived: sum of 2 quarters · filed 2017-11-02 | $16.15B 10-Q · filed 2017-11-02 | $21.82B derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-07-03 | $5.34B 10-Q · filed 2017-08-03 | $10.66B 10-Q · filed 2017-08-03 | $16.34B derived: sum of 3 quarters · filed 2018-02-21 | $21.56B derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-04-03 | $5.33B 10-Q · filed 2017-05-08 | $11.00B derived: sum of 2 quarters · filed 2018-02-21 | $16.23B derived: sum of 3 quarters · filed 2018-02-21 | $21.58B derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-01-03 | $5.67B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $10.90B derived: sum of 2 quarters · filed 2018-02-21 | $16.25B derived: sum of 3 quarters · filed 2018-02-21 | $21.54B 10-K · filed 2018-02-21 | |||
| 2015-09-27 | $5.22B 10-Q · filed 2016-11-04 | $10.58B derived: sum of 2 quarters · filed 2016-11-04 | $15.86B 10-Q · filed 2016-11-04 | $21.72B derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-28 | $5.36B 10-Q · filed 2016-08-04 | $10.64B 10-Q · filed 2016-08-04 | $16.49B derived: sum of 3 quarters · filed 2017-02-27 | $21.89B derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-29 | $5.28B 10-Q · filed 2016-05-10 | $11.13B derived: sum of 2 quarters · filed 2017-02-27 | $16.53B derived: sum of 3 quarters · filed 2017-02-27 | $22.57B derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-28 | $5.85B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $11.25B derived: sum of 2 quarters · filed 2017-02-27 | $17.29B derived: sum of 3 quarters · filed 2017-02-27 | $22.75B 10-K · filed 2017-02-27 | |||
| 2014-09-28 | $5.40B 10-Q · filed 2015-10-30 | $11.44B derived: sum of 2 quarters · filed 2015-10-30 | $16.89B 10-Q · filed 2015-10-30 | $22.85B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-29 | $6.04B 10-Q · filed 2015-07-31 | $11.49B 10-Q · filed 2015-07-31 | $17.45B derived: sum of 3 quarters · filed 2016-02-24 | $22.79B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-30 | $5.46B 10-Q · filed 2015-05-01 | $11.41B derived: sum of 2 quarters · filed 2016-02-24 | $16.75B derived: sum of 3 quarters · filed 2016-02-24 | $22.24B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-29 | $5.96B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $11.30B derived: sum of 2 quarters · filed 2016-02-24 | $16.79B derived: sum of 3 quarters · filed 2016-02-24 | $22.34B 10-K · filed 2016-02-24 | |||
| 2013-09-29 | $5.34B 10-Q · filed 2014-10-30 | $10.83B derived: sum of 2 quarters · filed 2014-10-30 | $16.39B 10-Q · filed 2014-10-30 | $22.39B derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | $5.49B 10-Q · filed 2014-08-01 | $11.04B 10-Q · filed 2014-08-01 | $17.05B derived: sum of 3 quarters · filed 2015-02-24 | $22.64B derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $5.55B 10-Q · filed 2014-05-02 | $11.56B derived: sum of 2 quarters · filed 2015-02-24 | $17.15B derived: sum of 3 quarters · filed 2015-02-24 | $22.30B derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-30 | $6.00B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $11.60B derived: sum of 2 quarters · filed 2015-02-24 | $16.74B derived: sum of 3 quarters · filed 2015-02-24 | $21.66B 10-K · filed 2015-02-24 | |||
| 2012-09-30 | $5.60B 10-Q · filed 2013-11-04 | $10.74B derived: sum of 2 quarters · filed 2013-11-04 | $15.65B 10-Q · filed 2013-11-04 | $20.99B derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2012-07-01 | $5.14B 10-Q · filed 2013-08-01 | $10.06B 10-Q · filed 2013-08-01 | $15.40B derived: sum of 3 quarters · filed 2014-02-21 | $20.47B derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2012-04-01 | $4.92B 10-Q · filed 2013-05-03 | $10.25B derived: sum of 2 quarters · filed 2014-02-21 | $15.32B derived: sum of 3 quarters · filed 2014-02-21 | $20.50B derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2012-01-01 | $5.34B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $10.41B derived: sum of 2 quarters · filed 2014-02-21 | $15.58B derived: sum of 3 quarters · filed 2014-02-21 | $20.36B 10-K · filed 2014-02-21 | |||
| 2011-10-02 | $5.07B 10-Q · filed 2012-11-09 | $10.24B derived: sum of 2 quarters · filed 2012-11-09 | $15.02B 10-Q · filed 2012-11-09 | $20.06B derived: sum of 4 quarters · filed 2013-02-22 | |||
| 2011-07-03 | $5.17B 10-Q · filed 2012-08-02 | $9.95B 10-Q · filed 2012-08-02 | $14.99B derived: sum of 3 quarters · filed 2013-02-22 | $19.58B derived: sum of 4 quarters · filed 2013-02-22 | |||
| 2011-04-03 | $4.78B 10-Q · filed 2012-05-07 | $9.82B derived: sum of 2 quarters · filed 2013-02-22 | $14.41B derived: sum of 3 quarters · filed 2013-02-22 | $19.04B derived: sum of 4 quarters · filed 2013-02-22 | |||
| 2011-01-02 | $5.04B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $9.63B derived: sum of 2 quarters · filed 2013-02-22 | $14.26B derived: sum of 3 quarters · filed 2013-02-22 | $18.79B 10-K · filed 2013-02-22 | |||
| 2010-10-03 | $4.59B 10-Q · filed 2011-11-08 | $9.22B derived: sum of 2 quarters · filed 2011-11-08 | $13.75B 10-Q · filed 2011-11-08 | $19.06B derived: sum of 4 quarters · filed 2012-02-23 | |||
| 2010-07-04 | $4.63B 10-Q · filed 2011-08-09 | $9.16B 10-Q · filed 2011-08-09 | $14.47B derived: sum of 3 quarters · filed 2012-02-23 | $18.90B derived: sum of 4 quarters · filed 2012-02-23 | |||
| 2010-04-04 | $4.53B 10-Q · filed 2011-05-10 | $9.84B derived: sum of 2 quarters · filed 2012-02-23 | $14.27B derived: sum of 3 quarters · filed 2012-02-23 | $18.72B derived: sum of 4 quarters · filed 2012-02-23 | |||
| 2010-01-03 | $5.31B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $9.75B derived: sum of 2 quarters · filed 2012-02-23 | $14.20B derived: sum of 3 quarters · filed 2012-02-23 | $18.45B 10-K · filed 2012-02-23 | |||
| 2009-09-27 | $4.43B 10-Q · filed 2010-11-10 | $8.88B derived: sum of 2 quarters · filed 2010-11-10 | $13.13B 10-Q · filed 2010-11-10 | $17.51B derived: sum of 4 quarters · filed 2011-02-25 | |||
| 2009-06-28 | $4.45B 10-Q · filed 2010-08-11 | $8.70B 10-Q · filed 2010-08-11 | $13.07B derived: sum of 3 quarters · filed 2011-02-25 | $17.85B derived: sum of 4 quarters · filed 2011-02-25 | |||
| 2009-03-29 | $4.25B 10-Q · filed 2010-05-10 | $8.62B derived: sum of 2 quarters · filed 2011-02-25 | $13.40B derived: sum of 3 quarters · filed 2011-02-25 | $18.15B derived: sum of 4 quarters · filed 2011-02-25 | |||
| 2008-12-28 | $4.37B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $9.15B derived: sum of 2 quarters · filed 2011-02-25 | $13.90B derived: sum of 3 quarters · filed 2011-02-25 | $18.51B 10-K · filed 2011-02-25 | |||
| 2008-09-28 | $4.77B 10-Q · filed 2009-11-04 | $9.53B derived: sum of 2 quarters · filed 2009-11-04 | $14.14B 10-Q · filed 2009-11-04 | ||||
| 2008-06-29 | $4.75B 10-Q · filed 2009-08-04 | $9.37B 10-Q · filed 2009-08-04 | |||||
| 2007-12-30 | $17.75B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |